Effect of anticovid plasma on COVID-19 among patients in intensive care unit of COVID hospital

Author:

Yamshikov Oleg N.1ORCID

Affiliation:

1. Kotovsk City Clinical Hospital; Derzhavin Tambov State University

Abstract

The spread of the SARS-CoV-2 virus and the increased mortality caused by it has led to the search and evaluation of available methods of drug therapy for patients, especially those who are in intensive care units of COVID hospitals. A feature of the course of coronavirus infection is its unpredictable nature and severity. In this regard, it became necessary to use targeted and powerful means of pathogenetic therapy. The lack of a specific treatment for COVID-19 brought to mind the possibility of passive immunotherapy, first through the transfusion of convalescent donor plasma, and then the plasma of vaccinated individuals. The purpose of such therapy is to introduce covid antibodies into the recipient's blood to neutralize the virus. At the same time, the question remains about the effectiveness of this treatment method in patients in serious and extremely serious condition in the intensive care unit of the COVID center. According to various studies, anticovid plasma is suitable for use in patients at the initial stages of the disease and in the presence of immunodeficiency in the patient. At the same time, the overall mortality in the intensive care unit and intensive care among severe and extremely severe patients may not decrease.

Publisher

Tambov State University - G.R. Derzhavin

Reference24 articles.

1. Cheng Y., Wong R., Soo Y. et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. J. Clin. Microbiol. Infect. Dis. 2005 Jan;24(1):44-6. DOI 10.1007/s10096-004-1271-9

2. Ko J.H., Seok H., Cho S. et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antivir. Ther. (Lond). 2018;23(7):617-22.

3. Blagodir A.L., Kirillov A.A. Commentary to Federal Law no. 125-FZ of July 20, 2012 “On blood donation and its components”. Moscow; 2013. (In Russian).

4. Zarubin M.V., Babushkin O.S., Zaznobov M.E., Agapitov E.A., Kurnosov N.V., Ikhiseeva L.V., Smirno-

5. va O.Yu., Belova O.A., Okhlopkova O.I., Rusanova M.A., Ilchenko S.V., Zhiburt E.B. Organization of blood collection in the conditions of the COVID-19 epidemic. Transfuziologiya = Transfusiology. 2021;22(1):4-12. (In Russian).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3